Skip to main content

Table 2 Standardized domain scores (%) and overall assessment (N = 19)

From: A technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapy

Guidelines

Scope and purpose

Stakeholder involvement

Rigor of development

Clarity of presentation

Applicability

Editorial independence

Overall assessment

USA 2007 [21]

77.78

50.00

7.29

80.56

24.75

29.17

Not recommended

Italy 2008 [22]

75.00

47.22

6.25

88.89

23.33

8.33

Not recommended

USA 2008 [23]

80.56

52.78

9.38

83.33

14.58

29.17

Not recommended

UK 2009 [24]

80.56

75.00

17.71

91.67

25.42

20.83

Not recommended

International 2011 [25]

69.44

50.00

19.79

80.56

29.17

70.83

Recommended with modifications

Germany 2011 [26]

69.44

41.67

6.25

75.00

10.42

25.00

Not recommended

STSG 2011 [27]

69.44

52.78

61.67

91.67

52.08

66.67

Recommended

Germany 2011 [28]

66.67

44.44

25.00

88.89

20.83

87.50

Recommended with modifications

Italy 2011 [29]

80.56

50.00

19.58

88.89

20.83

20.83

Not recommended

France 2012 [30]

86.11

50.00

52.08

83.33

22.92

0.00

Recommended with modifications

Canada 2012 [31]

83.33

55.56

45.83

80.56

35.42

83.33

Recommended with modifications

Europe 2013 [32]

83.33

52.78

25.00

77.78

21.25

58.33

Recommended with modifications

Spain 2015 [33]

83.33

58.33

12.50

88.89

25.50

50.00

Recommended with modifications

UK 2015 [34]

80.56

50.00

17.71

91.67

25.42

66.67

Recommended with modifications

India 2016 [35]

83.33

36.11

8.33

88.89

21.67

54.17

Recommended with modifications

Italy 2016 [36]

80.56

50.00

25.42

86.11

22.92

0.00

Not recommended

USA 2017 [37]

83.33

36.11

8.33

88.89

21.67

54.17

Recommended with modifications

China 2017 [38]

69.44

50.00

10.42

77.78

4.17

75.00

Recommended with modifications

ONS 2017 [39]

94.44

50.00

70.83

88.89

32.92

58.33

Recommended

Median

78.80

50.15

23.65

85.38

23.96

45.18